The store will not work correctly when cookies are disabled.
5-Nitro-2-(4-trimethoxyphenyl)-1H-benzimidazole
ID: ALA1092984
PubChem CID: 46845159
Max Phase: Preclinical
Molecular Formula: C16H15N3O5
Molecular Weight: 329.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(-c2nc3cc([N+](=O)[O-])ccc3[nH]2)c(OC)c1OC
Standard InChI: InChI=1S/C16H15N3O5/c1-22-13-7-5-10(14(23-2)15(13)24-3)16-17-11-6-4-9(19(20)21)8-12(11)18-16/h4-8H,1-3H3,(H,17,18)
Standard InChI Key: IRXXSDFWKUMWQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.9819 -15.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9807 -15.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6956 -16.3985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6938 -14.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4091 -15.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4094 -15.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1999 -16.2423 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6882 -15.5698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1994 -14.8977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5099 -15.5681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9221 -16.2840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7463 -16.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1594 -15.5690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7422 -14.8523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9193 -14.8557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9844 -15.5676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3981 -16.2814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5046 -14.1425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6796 -14.1451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1519 -14.1362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9769 -14.1330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2666 -14.7462 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5522 -15.1589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2664 -13.9212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11 12 1 0
2 3 1 0
12 13 2 0
3 6 2 0
13 14 1 0
1 2 2 0
14 15 2 0
15 10 1 0
8 10 1 0
5 4 2 0
13 16 1 0
6 7 1 0
16 17 1 0
7 8 1 0
15 18 1 0
8 9 2 0
18 19 1 0
9 5 1 0
14 20 1 0
4 1 1 0
20 21 1 0
5 6 1 0
10 11 2 0
22 23 2 0
22 24 1 0
1 22 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.31 | Molecular Weight (Monoisotopic): 329.1012 | AlogP: 3.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 99.51 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.05 | CX Basic pKa: 3.00 | CX LogP: 2.75 | CX LogD: 2.75 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.57 | Np Likeness Score: -0.84 |
References
1. Tonelli M, Simone M, Tasso B, Novelli F, Boido V, Sparatore F, Paglietti G, Pricl S, Giliberti G, Blois S, Ibba C, Sanna G, Loddo R, La Colla P.. (2010) Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives., 18 (8): [PMID:20359898] [10.1016/j.bmc.2010.02.037] |
2. Navarrete-Vázquez G, Hidalgo-Figueroa S, Torres-Piedra M, Vergara-Galicia J, Rivera-Leyva JC, Estrada-Soto S, Estrada-Soto S, León-Rivera I, Aguilar-Guardarrama B, Rios-Gómez Y, Villalobos-Molina R, Ibarra-Barajas M.. (2010) Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives., 18 (11): [PMID:20451399] [10.1016/j.bmc.2010.04.027] |